Sodium-glucose co-transporter-2 (SGLT-2) inhibition reduces glucose uptake to induce breast cancer cell growth arrest through AMPK/mTOR pathway

Zhou, J; Zhu, J; Yu, SJ; Ma, HL; Chen, J; Ding, XF; Chen, G; Liang, Y; Zhang, Q

Chen, G; Liang, Y (corresponding author), Taizhou Univ, Sch Med, Inst Tumor, 1139 Shi Fu Ave, Taizhou 318000, Zhejiang, Peoples R China.; Zhang, Q (corresponding author), Taizhou Univ, Taizhou Municipal Hosp, Dept Surg Oncol, 381-1 ZhongShan Rd E, Taizhou 318000, Zhejiang, Peoples R China.

BIOMEDICINE & PHARMACOTHERAPY, 2020; 132 ():

Abstract

Objective: The sodium-glucose transporter 2 (SGLT2) inhibitors Canagliflozin and Dapagliflozin are recently approved medications for type 2 diabetes. ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索